ight-time frequency in men above 50 years with LUTS/BPH: Prevalence, its predictive factors and association with nocturnal polyuria and comparative analysis of outcome after tamsulosin or silodosin therapy
Not Applicable
- Conditions
- Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptoms
- Registration Number
- CTRI/2020/07/026619
- Lead Sponsor
- King George Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All men aged > 50 years with LUTS/BPH for at least 3 month duration having IPSS score of 8 or greater.
Exclusion Criteria
1.Prostate cancer,
2.PSA > 4 ng/ml,
3.Urinary tract infection
4.Patients with h/o AUR or PUC placement or patients who are on PUC
5.Patients having renal failure or upper urinary tract dilatation.
6.Patients with h/o hematuria
7.Stricture urethra
8.Bladder calculus
9.Patients with GUTB
10.Patients with LUTS who are already on α-blockers within the past 1 month.
11.nervous system disease,
12.urolithiasis,
13.medical therapy that could affect the function of urination,
14.prostatic surgery, or pelvic surgery
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method